Centro Médico Teknon
Lung cancer stage 4 treatment cost in Spain typically includes essential diagnostics like a consultation with an oncologist ranging from $200 to $400. Primary treatment options such as lung cancer surgery run from $40,000 to $70,000, while stereotaxic radiosurgery costs $12,000 to $20,000. Total expenses depend on the medication protocol and facility tier, often providing 30-50% savings compared to the US. Top treatment centers are located in Madrid and Barcelona.
Typical Lung Cancer Stage 4 Treatment Costs in Spain
Bookimed Expert Insight: Patients seeking advanced precision medicine should prioritize centers with specialized oncology units. Dr. Antonio Cubillo Gracián at Hospital Universitario HM Sanchinarro leads a pioneering liquid biopsy program for tailored therapy. For complex cases, JCI-accredited Centro Médico Teknon offers high-tech surgical interventions in Barcelona. Those requiring specialized radiotherapy find value at GenesisCare, which utilizes CyberKnife technology across a global network of specialized clinics.
| Turkey | Austria | Spain | |
| Stereotaxic radiosurgery | from $4,500 | from $17,000 | from $12,000 |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Pneumonectomy | from $12,080 | from $50,000 | from $35,000 |
| Lung cancer surgery | from $17,000 | from $42,000 | from $40,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
No hidden fees – just official clinic prices. Pay at the clinic for Lung cancer stage 4 treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lung cancer stage 4 treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lung cancer stage 4 treatment journey.
Dr. Antonio Cubillo Gracián leads postgraduate research in oncology – shaping future specialists at HM CIOCC and USP CEU.
Dr. Joan Albanell Mestres is a leading oncologist who specializes in breast cancer. He earned his MBBS from the University Autónoma de Barcelona in 1989. He leads the breast cancer program at HM Delfos and oversees Oncology services at Clin del Mar in Spain.
Dr. Albanell has published 120 scientific articles, with over 9,000 citations. He directs cancer research at Del Mar. He is also an active member of GEICAM, CIBERONC, AIECA, and SEOM. He regularly contributes to important oncology research.